Genomic Health Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Genomic Health Inc (GHDX) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Genomic Health Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 442M vs -M combined for its competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+3.5% annualized vs trailing 12 months).
- Peer revenue share: Genomic Health Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
GHDX Sales vs. its Competitors, Q2 2019
Genomic Health Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
API endpoints for this dataset
For context: the Medical Laboratories industry grew revenue 9.0% year over year, combined, vs 12.9% for Genomic Health Inc. Genomic Health Inc's share of combined industry revenue moved from 0.18% to 0.19%, a gain of 0.01 percentage points.
Genomic Health Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Genomic Health Inc | Yes | Yes | Yes | No |
| High-Confidence Competitors (11) | ||||
| Similar Growth & Profitability (8) | 100.00 % (8 of 8) | 100.00 % (8 of 8) | 87.50 % (7 of 8) | 0.00 % (0 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
GHDX Stock Performance relative to its Competitors
GHDX Stock Performance relative to High-Confidence Competitors
GHDX Stock Performance relative to Similar Growth & Profitability Competitors
Genomic Health Inc's Competitors Named by the Company
Competitive relationships identified from Genomic Health Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Natera Inc | Company report | 85% |
| Veracyte Inc | Company report | 85% |
| Volitionrx Limited | Company report | 85% |
| Lunai Bioworks Inc | Company report | 85% |
| Genedx Holdings Corp | Company report | 85% |
| Guardant Health Inc | Company report | 85% |
| Quantum Cyber N v | Company report | 85% |
| Aspira Women s Health inc | Company report | 85% |
| Caris Life Sciences Inc | Company report | 85% |
| AWH | Company report | 85% |
| Geneoscopy | Company report | 85% |
| RENB | Company report | 85% |
| C-Scan | Company report | 85% |
| Mdxhealth Sa | Company report | 85% |
| Epi proColon | Company report | 85% |
| PillCam COLON | Company report | 85% |
| Prescient Metabiomics | Company report | 85% |
| Mainz Biomed | Company report | 85% |
| Odonate Therapeutics Inc | Company report | 85% |
| Motus Gi Holdings Inc | Company report | 85% |
| Illumina Inc | Company report | 85% |
| Hologic Inc | Company report | 85% |
| Neogenomics Inc | Company report | 85% |
| Dermtech Inc | Company report | 85% |
| Myriad Genetics Inc | Company report | 85% |
| Grail Inc | Company report | 85% |
| Invitae Corporation | Company report | 85% |
| Interpace Biosciences Inc | Company report | 85% |
| Fulgent Genetics Inc | Company report | 85% |
| Burning Rock Biotech Limited | Company report | 85% |
| Cardio Diagnostics Holdings Inc | Company report | 85% |
| Accustem Sciences Inc | Company report | 85% |
| Centogene N v | Company report | 85% |
| Htg Molecular Diagnostics Inc | Company report | 85% |
| Biodesix Inc | Company report | 85% |
| Insight Molecular Diagnostics Inc | Company report | 85% |
| Personalis Inc | Company report | 85% |
| Sophia Genetics Sa | Company report | 85% |
| Check Cap Ltd | Company report | 85% |
| Biocept Inc | Company report | 85% |
| Theralink Technologies Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Genomic Health Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.